U.S. flag

An official website of the United States government

NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp) AND Choroidal dystrophy, central areolar 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 1, 1996
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000014071.39

Allele description [Variation Report for NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp)]

NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp)

Gene:
PRPH2:peripherin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.1
Genomic location:
Preferred name:
NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp)
HGVS:
  • NC_000006.12:g.42721911G>A
  • NG_009176.2:g.5710C>T
  • NM_000322.5:c.424C>TMANE SELECT
  • NP_000313.2:p.Arg142Trp
  • NP_000313.2:p.Arg142Trp
  • NC_000006.11:g.42689649G>A
  • NG_009176.1:g.5710C>T
  • NM_000322.4:c.424C>T
Protein change:
R142W; ARG142TRP
Links:
OMIM: 179605.0022; dbSNP: rs61755783
NCBI 1000 Genomes Browser:
rs61755783
Molecular consequence:
  • NM_000322.5:c.424C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Choroidal dystrophy, central areolar 2 (CACD2)
Synonyms:
MACULAR DYSTROPHY, PROGRESSIVE; Choriodal Dystrophy, Central Areolar 2
Identifiers:
MONDO: MONDO:0013137; MedGen: C2751290; Orphanet: 75377; OMIM: 613105

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034318OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 1996)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Boon, C. J. F., Klevering, B. J., Cremers, F. P. M., Zonneveld-Vrieling, M. N., Theelen, T., Den Hollander, A. I., Hoyng, C. B. Central areolar choroidal dystrophy. Ophthalmology 116: 771-782, 2009.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Autosomal dominant central areolar choroidal dystrophy caused by a mutation in codon 142 in the peripherin/RDS gene.

Hoyng CB, Heutink P, Testers L, Pinckers A, Deutman AF, Oostra BA.

Am J Ophthalmol. 1996 Jun;121(6):623-9.

PubMed [citation]
PMID:
8644804

Details of each submission

From OMIM, SCV000034318.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 11 affected members from 7 families with central areolar choroidal dystrophy (CACD2; 613105), Hoyng et al. (1996) identified heterozygosity for a 664C-T transition in exon 1 of the PRPH2 gene, resulting in an arg142-to-trp (R142W) substitution. The mutation was also detected in a 65-year-old female family member who had 20/20 visual acuity bilaterally and no posterior pole abnormalities on ophthalmoscopy or fluorescein angiography. The mutation was not found in 7 other unaffected family members or in 200 control chromosomes.

Boon et al. (2009) identified the R142W mutation in 98 patients with CACD from 45 different Dutch families and noted that 96 (98%) of the patients originated from the southeast region of the Netherlands. Analysis of CA repeat markers and SNPs near the PRPH2 gene in 3 large families carrying the R142W mutation revealed an approximately 519-kb shared chromosomal segment, strongly suggesting that R142W represents a founder mutation. Carrier frequency of R142W was analyzed in 57 asymptomatic controls over 70 years of age from the same region of the Netherlands; the mutation was found in a 76-year-old man who reported no visual disturbances, but who was found to have early stage II CACD on ophthalmoscopic examination and fundus autofluorescence imaging.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024